138 related articles for article (PubMed ID: 12504772)
81. Quality of life and oral function in patients treated with radiation therapy for head and neck cancer.
Epstein JB; Robertson M; Emerton S; Phillips N; Stevenson-Moore P
Head Neck; 2001 May; 23(5):389-98. PubMed ID: 11295813
[TBL] [Abstract][Full Text] [Related]
82. DAHANCA 10 - Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group.
Overgaard J; Hoff CM; Hansen HS; Specht L; Overgaard M; Lassen P; Andersen E; Johansen J; Andersen LJ; Evensen JF; Alsner J; Grau C
Radiother Oncol; 2018 Apr; 127(1):12-19. PubMed ID: 29523409
[TBL] [Abstract][Full Text] [Related]
83. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer.
Bentzen SM; Saunders MI; Dische S
Radiother Oncol; 1999 Dec; 53(3):219-26. PubMed ID: 10660202
[TBL] [Abstract][Full Text] [Related]
84. Systematic Review and Meta-analysis of Conventionally Fractionated Concurrent Chemoradiotherapy versus Altered Fractionation Radiotherapy Alone in the Definitive Management of Locoregionally Advanced Head and Neck Squamous Cell Carcinoma.
Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):50-61. PubMed ID: 26454839
[TBL] [Abstract][Full Text] [Related]
85. Dose-finding study of docetaxel added to ifosfamide and cisplatin followed by concomitant capecitabine and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
Recchia F; Saggio G; Cesta A; Amiconi G; di Blasio A; Candeloro G; Valeriani M; Tombolini V; Rea S
Anticancer Res; 2006; 26(3B):2317-24. PubMed ID: 16821609
[TBL] [Abstract][Full Text] [Related]
86. Accelerated radiotherapy with delayed concomitant boost in locally advanced squamous cell carcinoma of the head and neck.
MacKenzie R; Balogh J; Choo R; Franssen E
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):589-95. PubMed ID: 10524410
[TBL] [Abstract][Full Text] [Related]
87. Proton radiation therapy.
Archambeau JO; Bennett GW; Levine GS; Cowen R; Akanuma A
Radiology; 1974 Feb; 110(2):445-57. PubMed ID: 4203944
[No Abstract] [Full Text] [Related]
88. Medullary carcinoma of the breast after radiation therapy for Hodgkin's disease in a young woman: report of a case.
Hwang KW; Woo OH; Koo BH; Yong HS; Kim A; Kang EY
Surg Today; 2006; 36(12):1105-7. PubMed ID: 17123141
[TBL] [Abstract][Full Text] [Related]
89. [Radiation therapy for head and neck cancer].
Mitsuhashi N; Akimoto T; Hayakawa K; Muramatsu H; Niibe H
Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Jan; 61(1):10-6. PubMed ID: 11218740
[TBL] [Abstract][Full Text] [Related]
90. Thyroid nodular disease after radiotherapy to the neck for childhood Hodgkin's disease.
Shafford EA; Kingston JE; Healy JC; Webb JA; Plowman PN; Reznek RH
Br J Cancer; 1999 May; 80(5-6):808-14. PubMed ID: 10360659
[TBL] [Abstract][Full Text] [Related]
91. Pilot study of nimorazole as a hypoxic-cell sensitizer with the "chart" regimen in head and neck cancer.
Cottrill CP; Bishop K; Walton MI; Henk JM
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):807-10. PubMed ID: 9845101
[TBL] [Abstract][Full Text] [Related]
92. Management of the pregnant patient with Hodgkin's disease.
Jacobs C; Donaldson SS; Rosenberg SA; Kaplan HS
Ann Intern Med; 1981 Dec; 95(6):669-75. PubMed ID: 7305142
[TBL] [Abstract][Full Text] [Related]
93. Radiation dose to the fetus during CyberKnife radiosurgery for a brain tumor in pregnancy.
Pantelis E; Antypas C; Frassanito MC; Sideri L; Salvara K; Lekas L; Athanasiou O; Piperis M; Salvaras N; Romanelli P
Phys Med; 2016 Jan; 32(1):237-41. PubMed ID: 26508017
[TBL] [Abstract][Full Text] [Related]
94. Chemotherapy and altered fractionation in head-and-neck cancer: in regard to Staar et al., IJROBP 2001;50:1161-1171.
Bentzen SM; Bernier J
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1423; author reply 1423-4. PubMed ID: 11955758
[No Abstract] [Full Text] [Related]
95. Comparison of passive-beam proton therapy, helical tomotherapy and 3D conformal radiation therapy in Hodgkin's lymphoma female patients receiving involved-field or involved site radiation therapy.
Horn S; Fournier-Bidoz N; Pernin V; Peurien D; Vaillant M; Dendale R; Fourquet A; Kirova YM
Cancer Radiother; 2016 Apr; 20(2):98-103. PubMed ID: 26992750
[TBL] [Abstract][Full Text] [Related]
96. Hodgkin's disease and pregnancy.
Gobbi PG; Attardo-Parrinello A; Danesino M; Motta C; Di Prisco AU; Rizzo SC; Ascari E
Haematologica; 1984; 69(3):336-41. PubMed ID: 6432646
[No Abstract] [Full Text] [Related]
97. A review on fetal dose in Radiotherapy: A historical to contemporary perspective.
Wong YM; Koh CWY; Lew KS; Chua CGA; Nei W; Tan HQ; Lee JCL; Mazonakis M; Damilakis J
Phys Med; 2023 Jan; 105():102513. PubMed ID: 36565555
[TBL] [Abstract][Full Text] [Related]
98. Expert opinion: Reconsidering How It Begins: Response to Gray Zone Article About Head and Neck Cancer in a Young Pregnant Woman.
Beadle BM; Bauman JE
Int J Radiat Oncol Biol Phys; 2023 Jan; 115(1):263-264. PubMed ID: 36152970
[No Abstract] [Full Text] [Related]
99. Challenges and opportunities for proton therapy during pregnancy.
Blommaert J; De Saint-Hubert M; Depuydt T; Oldehinkel E; Poortmans P; Amant F; Lambrecht M
Acta Obstet Gynecol Scand; 2024 Apr; 103(4):767-774. PubMed ID: 37491770
[TBL] [Abstract][Full Text] [Related]
100. Revisiting fetal dose during radiation therapy: evaluating treatment techniques and a custom shield.
Owrangi AM; Roberts DA; Covington EL; Hayman JA; Masi KM; Lee C; Moran JM; Prisciandaro JI
J Appl Clin Med Phys; 2016 Sep; 17(5):34-46. PubMed ID: 27685109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
